These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6684041)

  • 1. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
    Branzi A; Specchia S; Binetti G; Magelli C; Zannoli R; Magnani B
    Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
    Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
    Klein W; Brandt D; Maurer E
    Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
    Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
    Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
    Kupper W; Schütt M; Bleifeld W
    Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
    Muir AL; Hannan WJ; Dewhurst NG; Slessor IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
    Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
    Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
    J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
    Ek L; Björkman JA; Carlsson E; Johansson B
    Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
    Doering W; Wauer B; Isbary J
    Acta Med Scand Suppl; 1982; 659():307-14. PubMed ID: 6127897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock.
    Reiz S; Friedman A
    Acta Anaesthesiol Scand; 1980; 24(1):5-10. PubMed ID: 7376804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
    Shiu MF; Ireland MA; Littler WA
    Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
    Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
    Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of intravenous prenalterol in severe heart failure.
    Kirlin PC; Pitt B
    Am J Cardiol; 1981 Mar; 47(3):670-5. PubMed ID: 7468501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
    Awan NA; Needham KE; Evenson MK; Win A; Mason DT
    Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Prenalterol on left ventricular function of coronary patients].
    Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
    Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.